Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Omicron-induced interferon signalling prevents influenza A virus infection

Denisa Bojkova, Marco Bechtel, Tamara Rothenburger, Joshua D. Kandler, Lauren Hayes, Ruth Olmer, Martin Ulrich, Danny Jonigk, Sandra Ciesek, View ORCID ProfileMark N. Wass, View ORCID ProfileMartin Michaelis, View ORCID ProfileJindrich Cinatl jr.
doi: https://doi.org/10.1101/2022.09.06.506799
Denisa Bojkova
1Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Bechtel
1Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamara Rothenburger
1Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua D. Kandler
1Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Hayes
2School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Olmer
3Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), REBIRTH-Research Center for Translational Regenerative Medicine, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Ulrich
3Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), REBIRTH-Research Center for Translational Regenerative Medicine, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danny Jonigk
4Institute of Pathology, Hannover Medical School (MHH), Carl-Neuberg-Straße, 1 30625 Hannover, Germany
5Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), The German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Hannover Medical School (MHH), Carl-Neuberg-Straße 1, 30625 Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Ciesek
1Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany
6German Center for Infection Research, DZIF, External partner site, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
7Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Branch Translational Medicine und Pharmacology, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark N. Wass
2School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark N. Wass
Martin Michaelis
2School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Michaelis
  • For correspondence: Cinatl@em.uni-frankfurt.de M.Michaelis@kent.ac.uk
Jindrich Cinatl jr.
1Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany
8Dr. Petra Joh-Forschungshaus, Komturstr. 3A, 60528 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jindrich Cinatl jr.
  • For correspondence: Cinatl@em.uni-frankfurt.de M.Michaelis@kent.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Recent findings in permanent cell lines suggested that SARS-CoV-2 Omicron BA.1 induces a stronger interferon response than Delta. Here, we show that BA.1 and BA.5 but not Delta induce an antiviral state in air-liquid interface (ALI) cultures of primary human bronchial epithelial (HBE) cells and primary human monocytes. Both Omicron subvariants caused the production of biologically active type I (α/β) and III (λ) interferons and protected cells from super-infection with influenza A viruses. Notably, abortive Omicron infection of monocytes was sufficient to protect monocytes from influenza A virus infection. Interestingly, while influenza-like illnesses surged during the Delta wave in England, their spread rapidly declined upon the emergence of Omicron. Mechanistically, Omicron-induced interferon signalling was mediated via double-stranded RNA recognition by MDA5, as MDA5 knock-out prevented it. The JAK/ STAT inhibitor baricitinib inhibited the Omicron-mediated antiviral response, suggesting it is caused by MDA5-mediated interferon production, which activates interferon receptors that then trigger JAK/ STAT signalling. In conclusion, our study 1) demonstrates that only Omicron but not Delta induces a substantial interferon response in physiologically relevant models, 2) shows that Omicron infection protects cells from influenza A virus super-infection, and 3) indicates that BA.1 and BA.5 induce comparable antiviral states.

Competing Interest Statement

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 06, 2022.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Omicron-induced interferon signalling prevents influenza A virus infection
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Omicron-induced interferon signalling prevents influenza A virus infection
Denisa Bojkova, Marco Bechtel, Tamara Rothenburger, Joshua D. Kandler, Lauren Hayes, Ruth Olmer, Martin Ulrich, Danny Jonigk, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl jr.
bioRxiv 2022.09.06.506799; doi: https://doi.org/10.1101/2022.09.06.506799
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Omicron-induced interferon signalling prevents influenza A virus infection
Denisa Bojkova, Marco Bechtel, Tamara Rothenburger, Joshua D. Kandler, Lauren Hayes, Ruth Olmer, Martin Ulrich, Danny Jonigk, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl jr.
bioRxiv 2022.09.06.506799; doi: https://doi.org/10.1101/2022.09.06.506799

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4086)
  • Biochemistry (8759)
  • Bioengineering (6478)
  • Bioinformatics (23339)
  • Biophysics (11747)
  • Cancer Biology (9147)
  • Cell Biology (13245)
  • Clinical Trials (138)
  • Developmental Biology (7413)
  • Ecology (11367)
  • Epidemiology (2066)
  • Evolutionary Biology (15086)
  • Genetics (10397)
  • Genomics (14008)
  • Immunology (9118)
  • Microbiology (22039)
  • Molecular Biology (8777)
  • Neuroscience (47356)
  • Paleontology (350)
  • Pathology (1420)
  • Pharmacology and Toxicology (2480)
  • Physiology (3703)
  • Plant Biology (8049)
  • Scientific Communication and Education (1431)
  • Synthetic Biology (2208)
  • Systems Biology (6015)
  • Zoology (1249)